Abano Healthcare beat guidance as it lifted first-half earnings 62 per cent from a year earlier on an expanding dental network, giving the board confidence in the current strategy as they rejected a partial takeover bid by dissident shareholders as significantly undervaluing the business.
Underlying profit rose to $6.3 million in the six months ended November 30 from $3.9m a year earlier, and ahead of last month's forecast for earnings between $5m and $5.6m, the Auckland-based company said in a statement. Revenue increased 8.1 per cent to $116.8m, while net profit was up 73 per cent to $5.9m. Abano declared an interim dividend of 16 cents per share.
Abano released the unaudited earnings ahead of the formal release on December 21 to give shareholders "timely information" about the company, which is under a takeover offer from Anya and Peter Hutson and James Reeve of Healthcare Partners, who have offered $10 a share to build a 50.01 per cent controlling stake in the healthcare investor.
The shares last traded at $7.99 and have gained 5.4 per cent so far this year.
The company's board has previously warned investors to wait for their recommendation, and today rejected the effective price of $9.84, which excludes the dividend, as being too low and below the bottom end of independent adviser Grant Samuel's valuation range of $9.95-to-$11.96 a share. The directors also said the offer wasn't for all of an investor's shares and acceptances could be scaled down to just 38 per cent.